Evaluation of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy: Is there a need for a more rational design?
Jian-Ming
JM
Xu
Angelo
A
Paradiso
Howard L
HL
McLeod
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015195:Drug Design; D004341:Drug Evaluation; D066246:ErbB Receptors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D066246:ErbB Receptors